BioSpace News Archive

Biotech Bay

Meditrina Welcomes Senior Vice President of Global Sales to Lead Expansion Efforts and Manage Rapid Growth

Meditrina, a leader in gynecologic medical devices, announced the expansion of its leadership team with the hiring of Ray Gerena, as Senior Vice President of Global Sales.

May 13, 2024
·
2 min read
BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000

On May 10, 2024, the BGI-Heilongjiang Omics Health Axis Intelligent Laboratory was inaugurated in Harbin, Heilongjiang province, China, marking a significant advance in the province’s efforts to address public health challenges.

May 13, 2024
·
2 min read
Almirall Delivers Strong Start of 2024 – Q1 Net Sales Growth of 6.6% Overall and 18% in the European Dermatology Business, Driven by Biologics and Solid Performance of Broad Product Portfolio

Almirall, S.A. a global biopharmaceutical company based in Barcelona, announced its financial results from the first quarter 2024.

May 13, 2024
·
6 min read
Business

Macomics and IFOM (the AIRC Institute of Molecular Oncology) Announce Macrophage Scientific Collaboration

Macomics Ltd, a leader in macrophage drug discovery, announces that it has entered a scientific collaboration with Prof. Massimiliano Pagani from the IFOM, one of Italy’s leading research institutes in Cancer Research.

May 13, 2024
·
4 min read
Genetown

Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)

Fractyl Health, Inc., a metabolic therapeutics company focused on pioneering new approaches for the treatment of obesity and type 2 diabetes, announced 6-month follow-up data from its enrolling German real-world registry study of Revita for T2D.

May 13, 2024
·
7 min read
Pharm Country

Dramatic Increase in Fentanyl Seized by Authorities in Last Six Years

The number of illicit fentanyl seizures by law enforcement in the United States grew by more than 1,700 percent between 2017 and 2023, according to a new analysis.

May 13, 2024
·
4 min read
Pharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses

Pharvaris announced the acceptance of abstracts for presentation at three upcoming congresses: the 20th Annual Congress of International Drug Discovery Science and Technology ; the 2024 Eastern Allergy Conference ; and the European Academy of Allergy and Clinical Immunology Congress 2024.

May 13, 2024
·
3 min read
Drug Development

Merck Provides Update on Phase 3 KeyVibe-010 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab as Adjuvant Treatment for Patients With Resected High-Risk Melanoma

Merck, known as MSD outside of the United States and Canada, announced the discontinuation of the vibostolimab and pembrolizumab coformulation arm of the Phase 3 KeyVibe-010 trial.

May 13, 2024
·
52 min read
Business

Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights

Tourmaline Bio, Inc. announced its financial results for the first quarter ended March 31, 2024 and outlined recent business highlights.

May 13, 2024
·
8 min read
Business

Galera Reports First Quarter 2024 Financial Results and Recent Corporate UpdatesCompany’s evaluation of potential strategic alternatives progresses with goal to maximize stockholder value

Galera Therapeutics, Inc. announced financial results for the first quarter ended March 31, 2024, and provided recent corporate updates.

May 13, 2024
·
7 min read